Physician profile
Paul M Sethi
NPI 1578536025
$1,460,069.29
in general payments reported to CMS, 2019-2025
28 companies · $419K in 2025
The $419K reported for 2025 was more than what 99% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $221K · 2020: $108K · 2021: $152K · 2022: $192K · 2023: $151K · 2024: $217K · 2025: $419K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $334K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $304K · Royalty Or License: $99K · Travel and Lodging: $34K · Food and Beverage: $13K · Education: $2,200 · Honoraria: $1,000 · Gift: $39.49.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $333,992.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $303,792.50 |
| Royalty Or License | $99,095.19 |
| Travel and Lodging | $33,531.02 |
| Food and Beverage | $13,124.68 |
| Education | $2,200.00 |
| Honoraria | $1,000.00 |
| Gift | $39.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $889,559.87 | 2019-2025 | Arthrex |
| Shoulder Innovations, INC. | $184,221.40 | 2025 | Inset System |
| Pacira Pharmaceuticals Incorporated | $178,166.08 | 2019-2025 | Exparel, Iovera, Zilretta |
| Zimmer Biomet Holdings, INC. | $91,723.80 | 2022-2025 | Tapestry, Juggerknotless Soft Anchor, Comprehensive Shoulder System |
| Pacira Therapeutics, INC. | $85,002.66 | 2019-2021 | |
| Catalyst Orthoscience | $10,177.08 | 2020-2024 | R1 Reverse Shoulder System, Catalyst Csr Shoulder System, Archer 3d Software |
| Medical Device Business Services, INC. | $8,065.82 | 2019 | |
| Stryker Corporation | $3,819.38 | 2021-2024 | Blueprint Patient Specific Instrumentation, Aequalis Perform Reversed, Aequalis Perform |
| Biopoly LLC | $3,568.27 | 2023-2025 | Biopoly Radial Head Implant |
| Miach Orthopaedics, INC. | $894.37 | 2022-2025 | |
| Smith+Nephew, INC. | $744.17 | 2019-2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium, Bone Anchors With Arthroscopic Delivery System, Na |
| Gotham Surgical Solutions & Devices, INC. | $736.84 | 2019-2025 | |
| Wright Medical Technology, INC. | $503.11 | 2019 | |
| Coloplast Corp | $471.47 | 2019 | |
| Exactech, INC. | $454.20 | 2019-2024 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $400.00 | 2020 | |
| Medacta USA, INC. | $394.03 | 2023-2025 | Primary Shoulder, Gmk Sphere, Mecta |
| Joint Restoration Foundation, INC. | $289.48 | 2019 | |
| Medi-Tate Ltd | $206.50 | 2023 | Itind System |
| Vericel Corporation | $152.18 | 2022-2025 | Maci |
| Micromed INC | $112.27 | 2019 | |
| Encore Medical, Lp | $108.78 | 2019 | |
| Moximed, INC | $74.49 | 2025 | Misha Knee System, Small, Left |
| Gemini Mountain Medical, LLC | $69.84 | 2021 | |
| Abanza INC. | $58.75 | 2025 | Washercap Mini Fixation System 4.5mm, Washercap Fixation System 10mm |
| Djo, LLC | $47.65 | 2024 | Cmf |
| Arcuro Medical INC | $33.25 | 2024 | Superball |
| Aesculap Biologics, LLC | $13.55 | 2023 | Novocart 3d |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$73,887.36 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
$202,484.72 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Sethi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.